NR4A1 and ovarian clear cell cancer: We compared the expression in cell lines from PARP1 inhibitor treatable cancers (triple negative breast and high grade serous cancers) with cell lines from PARP1 inhibitor not-treatable cancers (hormone receptors-breast cancer and ovarian clear cell cancer) (see Materials and Methods).